Note : les liens hypertextes menant vers d’autres sites ne sont pas mis à jour de façon continue. Il est possible qu’un lien devienne introuvable. Veuillez alors utiliser les outils de recherche pour retrouver l’information désirée.
Bibliographie
Les cahiers de MedActuel. Le zona : la ceinture de feu!, L’actualité médicale, 5 décembre 2007. American Academy of Dermatology. Patient Education - Herpes zoster, American Academy of Dermatology. [Consulté le 23 novembre 2010]. www.aad.org Ask DrWeil, Polaris Health (Ed). Q & A Library - Shutting out shingles?, DrWeil.com. [Consulté le 23 novembre 2010]. www.drweil.com Association médicale du Canada (Ed). Grand public, Maladies - Zona, Amc.ca. [Consulté le 23 novembre 2010]. www.cma.ca Dre Boulanger, Aline. Comprendre le zona, Virage, décembre 2005 – janvier 2006. Ernst E, Pittler MH et Wider B (Ed). The Desktop Guide to Complementary and Alternative Medicine : an evidence-based approach, Mosby Elsevier, Angleterre, 2006. Mayo Foundation for Medical Education and Research (Ed). Diseases & Conditions - Shingles, MayoClinic.com. [Consulté le 23 novembre 2010]. www.mayoclinic.com National Library of Medicine (Ed). PubMed, NCBI. [Consulté le 23 novembre 2010]. www.ncbi.nlm.nih.gov Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009 Mar;84(3):274-80. Review. Texte intégral : www.mayoclinicproceedings.com The Natural Pharmacist (Ed). Conditions - Shingles (Herpes Zoster), ConsumerLab.com. [Consulté le 23 novembre 2010]. www.consumerlab.com UpToDate. [Consulté le 23 novembre 2010]. www.uptodate.com
Notes
1. Irwin MR, Pike JL, et al. Effects of a behavioral intervention, Tai Chi Chih, on varicella-zoster virus specific immunity and health functioning in older adults.Psychosom Med. 2003 Sep-Oct;65(5):824-30. 2. Rumsfield JA, West DP. Topical capsaicin in dermatologic and peripheral pain disorders.DICP. 1991 Apr;25(4):381-7. Review. 3. Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis.Drugs Aging. 1995 Oct;7(4):317-28. Review. 4. Watson CP, Tyler KL, et al. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993 May-Jun;15(3):510-26. 5. Peikert A, Hentrich M, Ochs G. Topical 0.025% capsaicin in chronic post-herpetic 5euralgia: efficacy, predictors of response and long-term course. J Neurol. 1991 Dec;238(8):452-6. 6. Billigmann P. [Enzyme therapy--an alternative in treatment of herpes zoster. A controlled study of 192 patients] Fortschr Med. 1995 Feb 10;113(4):43-8. German. 7. Kleine MW, Stauder GM, Beese EW. The intestinal absorption of orally administered hydrolytic enzymes and their effects in the treatment of acute herpes zoster as compared with those of oral acyclovir therapy. Phytomedicine. 1995;2:7–15. Étude décrite dans : The Natural Pharmacist (Ed). Conditions - Shingles (Herpes Zoster), ConsumerLab.com. [Consulté le 5 février 2008]. www.consumerlab.com 8. Ernst E, Pittler MH et Wider B (Ed). The Desktop Guide to Complementary and Alternative Medicine : an evidence-based approach, Mosby Elsevier, Angleterre, 2006, p. 162. 9. Association médicale du Canada (Ed). Grand public, Maladies - Zona, Amc.ca. [Consulté le 23 novembre 2010]. www.cma.ca 10. Davies SJ, Harding LM, Baranowski AP. A novel treatment of postherpetic neuralgia using peppermint oil.Clin J Pain. 2002 May-Jun;18(3):200-2. 11. Ask DrWeil, Polaris Health (Ed). Q & A Library - Shutting out shingles?, DrWeil.com. [Consulté le 23 novembre 2010]. www.drweil.com 12. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ. 2000 Sep 30;321(7264):794-6. 13. Helgason S, Sigurdsson J, Gudmundsson S. The clinical course of herpes zoster: a prospective study in primary care. European Journal of General Practice. 2:12-16. March, 1996. 14. Merck Frosst Canada. Zostavax – Monographie de produit. [Consulté le 30 septembre 2009]. www.merckfrosst.ca 15. Schmader K, George LK, et al. Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc. 1998 Aug;46(8):973-7. 16. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster?Lancet Infect Dis. 2004 Jan;4(1):26-33. Review. 17. Arndt V, Vine MF, Weigle K. Environmental chemical exposures and risk of herpes zoster. Environ Health Perspect. 1999 Oct;107(10):835-41. 18. Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi. Irwin MR, Olmstead R, Oxman MN. J Am Geriatr Soc. 2007 Apr;55(4):511-7.